Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nurden

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
Different activation states of GP IIb/IIIa complexes in plateletsA T Nurden, C Poujol, P Nurden
British Journal of Haematology|March 1, 1997
Ultrastructural analysis of the distribution of the vitronectin receptor (alpha v beta 3) in human platelets and megakaryocytes reveals an intracellular pool and labelling of the alpha-granule membraneC Poujol, A T Nurden, P Nurden
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 25, 2002
[From the physiopathology of thrombosis to therapeutic targets]P Nurden, S Ndoko, A T Nurden
Bailliere'S Clinical Haematology|February 1, 1997
The evolution of megakaryocytes to plateletsP Nurden, C Poujol, A T Nurden
Seminars in Hematology|July 1, 1994
Two-way trafficking of membrane glycoproteins on thrombin-activated human plateletsP Nurden, E Heilmann, A Paponneau, et al.
Advances in Experimental Medicine and Biology|September 14, 2001
Are patients with Glanzmann thrombasthenia and the Bernard-Soulier syndrome protected against atherosclerosis?A T Nurden, P Nurden, J N George
Journal of Thrombosis and Haemostasis : JTH|July 28, 2009
Altered megakaryocytopoiesis in von Willebrand type 2B diseaseA T Nurden, A B Federici, P Nurden
British Journal of Haematology|February 18, 2003
Heterozygotes in the bernard-soulier syndrome do not necessarily have giant platelets or thrombocytopeniaA T Nurden, R Combrié, S Claeyssens, et al.
Platelets|June 24, 2006
Ultrastructural analysis of the distribution of von Willebrand factor and fibrinogen in platelet aggregates formed in the PFA-100C Poujol, A Nurden, A Paponneau, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspectsA T Nurden, C Poujol, C Durrieu-Jais, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
Different activation states of GP IIb/IIIa complexes in plateletsA T Nurden, C Poujol, P Nurden
British Journal of Haematology|March 1, 1997
Ultrastructural analysis of the distribution of the vitronectin receptor (alpha v beta 3) in human platelets and megakaryocytes reveals an intracellular pool and labelling of the alpha-granule membraneC Poujol, A T Nurden, P Nurden
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 25, 2002
[From the physiopathology of thrombosis to therapeutic targets]P Nurden, S Ndoko, A T Nurden
Bailliere'S Clinical Haematology|February 1, 1997
The evolution of megakaryocytes to plateletsP Nurden, C Poujol, A T Nurden
Seminars in Hematology|July 1, 1994
Two-way trafficking of membrane glycoproteins on thrombin-activated human plateletsP Nurden, E Heilmann, A Paponneau, et al.
Advances in Experimental Medicine and Biology|September 14, 2001
Are patients with Glanzmann thrombasthenia and the Bernard-Soulier syndrome protected against atherosclerosis?A T Nurden, P Nurden, J N George
Journal of Thrombosis and Haemostasis : JTH|July 28, 2009
Altered megakaryocytopoiesis in von Willebrand type 2B diseaseA T Nurden, A B Federici, P Nurden
British Journal of Haematology|February 18, 2003
Heterozygotes in the bernard-soulier syndrome do not necessarily have giant platelets or thrombocytopeniaA T Nurden, R Combrié, S Claeyssens, et al.
Platelets|June 24, 2006
Ultrastructural analysis of the distribution of von Willebrand factor and fibrinogen in platelet aggregates formed in the PFA-100C Poujol, A Nurden, A Paponneau, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspectsA T Nurden, C Poujol, C Durrieu-Jais, et al.
Pageof 8